Skip Navigation LinksHome > March 2013 - Volume 56 - Issue 1 > Neonatal Abstinence Syndrome: Treatment and Pediatric Outco...
Clinical Obstetrics & Gynecology:
doi: 10.1097/GRF.0b013e31827feea4
Substance Abuse and Pregnancy

Neonatal Abstinence Syndrome: Treatment and Pediatric Outcomes

LOGAN, BETH A. MA*; BROWN, MARK S. MD, MSPH; HAYES, MARIE J. PhD*,‡

Collapse Box

Abstract

Recent rise in rates of opiate replacement therapy among pregnant women have resulted in increasing number of infants requiring treatment for neonatal abstinence syndrome (NAS). Short-term and long-term developmental outcomes associated with prenatal opiate exposure are discussed, including symptoms and severity of NAS, and early cognitive and motor delays. Maternal and infant risk factors are discussed, and include patterns of maternal substance use during pregnancy, genetic risk, polysubstance exposure pharmacological treatment for NAS and breastfeeding. The importance of characterizing corollary environmental risk factors is also considered.

© 2013 Lippincott Williams & Wilkins, Inc.

Login

Article Tools

Share

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.

Readers Of this Article Also Read